Myosin IIa activation is crucial in breast cancer derived galectin-1 mediated tolerogenic dendritic cell differentiation

Biochimica et Biophysica Acta - General Subjects

Volumn 1840, Issue 6, 2014, Pages 1965-1976

  Cheng, Da En ^a   Hung, Jen Yu ^b,c   Huang, Ming Shyan ^b,c   Hsu, Ya Ling ^a   Lu, Chi Yu ^d   Tsai, Eing Mei ^a   Hou, Ming Feng ^a   Kuo, Po Lin ^a,c,d  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Breast cancer; Dendritic cell; Endocytosis; Galectin 1; Myosin IIa

Indexed keywords

BLEBBISTATIN; CAVEOLIN; CD14 ANTIGEN; CD16 ANTIGEN; GALECTIN 1; GENISTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 4; MYOSIN IIA; MYOSIN LIGHT CHAIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER IMMUNOTHERAPY; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; ENDOCYTOSIS; HUMAN; IMMUNOMODULATION; IN VIVO STUDY; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; TUMOR MICROENVIRONMENT; XENOGRAFT;

BREAST CANCER; DENDRITIC CELL; ENDOCYTOSIS; GALECTIN-1; MYOSIN IIA;

ANIMALS; BREAST NEOPLASMS; CELL DIFFERENTIATION; DENDRITIC CELLS; ENDOCYTOSIS; FEMALE; GALECTIN 1; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; HUMANS; IMMUNE TOLERANCE; MICE; MICE, INBRED BALB C; NONMUSCLE MYOSIN TYPE IIA;

EID: 84897420750     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2014.01.026     Document Type: Article

References (51)

1. J.M. Ilarregui, D.O. Croci, G.A. Bianco, M.A. Toscano, M. Salatino, M.E. Vermeulen, J.R. Geffner, and G.A. Rabinovich Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10 Nat. Immunol. 10 2009 981 991
2. S. Gregori, D. Tomasoni, V. Pacciani, M. Scirpoli, M. Battaglia, C.F. Magnani, E. Hauben, and M.-G. Roncarolo Differentiation of type 1T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway Blood 116 2010 935 944
3. S. Ohki, M. Shibata, K. Gonda, T. Machida, T. Shimura, I. Nakamura, T. Ohtake, Y. Koyama, S. Suzuki, and H. Ohto Circulating myeloid-derived suppressor cells are increased and correlate to immune suppression, inflammation and hypoproteinemia in patients with cancer Oncol. Rep. 28 2012 453 458
4. M. Saito, M. Nagasawa, H. Takada, T. Hara, S. Tsuchiya, K. Agematsu, M. Yamada, N. Kawamura, T. Ariga, and I. Tsuge Defective IL-10 signaling in hyper-IgE syndrome results in impaired generation of tolerogenic dendritic cells and induced regulatory T cells J. Exp. Med. 208 2011 235 249
5. J.M. Ilarregui, and G.A. Rabinovich Tolerogenic dendritic cells in the control of autoimmune neuroinflammation: an emerging role of protein-glycan interactions Neuroimmunomodulation 17 2010 157 160
6. + T cells and reduced cancer cell adherence Clin. Exp. Metastasis 29 2012 561 572
7. P.-L. Kuo, J.-Y. Hung, S.-K. Huang, S.-H. Chou, D.-E. Cheng, Y.-J. Jong, C.-H. Hung, C.-J. Yang, Y.-M. Tsai, and Y.-L. Hsu Lung cancer-derived galectin-1 mediates dendritic cell anergy through inhibitor of DNA binding 3/IL-10 signaling pathway J. Immunol. 186 2011 1521 1530
8. M.C. Carlsson, C.I. Balog, O. Kilsgård, T. Hellmark, O. Bakoush, M. Segelmark, M. Fernö, H. Olsson, J. Malmström, and M. Wuhrer Different fractions of human serum glycoproteins bind galectin-1 or galectin-8, and their ratio may provide a refined biomarker for pathophysiological conditions in cancer and inflammatory disease Biochim. Biophys. Acta Gen. Subj. 1820 2012 1366 1372
9. P. Fritz, R. Seizer-Schmidt, T.E. Mürdter, H.K. Kroemer, W. Aulitzky, S. André, J. Hans-Gabius, G. Friedel, H. Toomes, and I. Siegle Ligands for Viscum album agglutinin and galectin-1 in human lung cancer: is there any prognostic relevance? Acta Histochem. 101 1999 239 253
10. N. Horiguchi, K.-i. Arimoto, A. Mizutani, Y. Endo-Ichikawa, H. Nakada, and S. Taketani Galectin-1 induces cell adhesion to the extracellular matrix and apoptosis of non-adherent human colon cancer Colo201 cells J. Biochem. 134 2003 869 874
11. E. Huang, Y. Chen, Y. Chen, I. Lin, C. Wang, W. Su, P. Chuang, and K. Yang A novel radioresistant mechanism of galectin-1 mediated by H-Ras-dependent pathways in cervical cancer cells Cell Death Dis. 3 2012 e251
12. E.J. Jung, H.G. Moon, B.I. Cho, C.Y. Jeong, Y.T. Joo, Y.J. Lee, S.C. Hong, S.K. Choi, W.S. Ha, and J.W. Kim Galectin1 expression in cancerassociated stromal cells correlates tumor invasiveness and tumor progression in breast cancer Int. J. Cancer 120 2007 2331 2338
13. O. Roda, E. Ortiz-Zapater, N. Martínez-Bosch, R. Gutiérrez-Gallego, M. Vila-Perelló, C. Ampurdanés, H.J. Gabius, S. André, D. Andreu, and F.X. Real Galectin-1 is a novel functional receptor for tissue plasminogen activator in pancreatic cancer Gastroenterology 136 2009 1379 1390 (e1375)
14. H.-J. Kim, H.-K. Jeon, Y.J. Cho, Y. Park, J.-J. Choi, I.-G. Do, S.Y. Song, Y.-Y. Lee, C.H. Choi, and T.-J. Kim High galectin-1 expression correlates with poor prognosis and is involved in epithelial ovarian cancer proliferation and invasion Eur. J. Cancer 48 2012 1914 1921
15. M.-H. Wu, H.-C. Hong, T.-M. Hong, W.-F. Chiang, Y.-T. Jin, and Y.-L. Chen Targeting galectin-1 in carcinoma-associated fibroblasts inhibits oral squamous cell carcinoma metastasis by downregulating MCP-1/CCL2 expression Clin. Cancer Res. 17 2011 1306 1316
16. R. Novak, S. Dabelic, and J. Dumic Galectin-1 and galectin-3 expression profiles in classically and alternatively activated human macrophages Biochim. Biophys. Acta Gen. Subj. 1820 2012 1383 1390
17. J.A. Fulcher, S.T. Hashimi, E.L. Levroney, M. Pang, K.B. Gurney, L.G. Baum, and B. Lee Galectin-1-matured human monocyte-derived dendritic cells have enhanced migration through extracellular matrix J. Immunol. 177 2006 216 226
18. K. Jaqaman, H. Kuwata, N. Touret, R. Collins, W.S. Trimble, G. Danuser, and S. Grinstein Cytoskeletal control of CD36 diffusion promotes its receptor and signaling function Cell 146 2011 593 606
19. B.I. Freedman, P.J. Hicks, M.A. Bostrom, M.E. Cunningham, Y. Liu, J. Divers, J.B. Kopp, C.A. Winkler, G.W. Nelson, and C.D. Langefeld Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans Kidney Int. 75 2009 736 745
20. V. Marigo, A. Nigro, A. Pecci, D. Montanaro, M. Di Stazio, C.L. Balduini, and A. Savoia Correlation between the clinical phenotype of MYH9-related disease and tissue distribution of class II nonmuscle myosin heavy chains Genomics 83 2004 1125 1133
21. A. Pecci, E. Panza, N. PujolMoix, C. Klersy, F. Di Bari, V. Bozzi, P. Gresele, S. Lethagen, F. Fabris, and C. Dufour Position of nonmuscle myosin heavy chain IIA (NMMHCIIA) mutations predicts the natural history of MYH9related disease Hum. Mutat. 29 2008 409 417
22. M. Seri, A. Pecci, F. Di Bari, R. Cusano, M. Savino, E. Panza, A. Nigro, P. Noris, S. Gangarossa, and B. Rocca MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness Medicine 82 2003 203
23. W.-F. Chiang, S.-Y. Liu, L.-Y. Fang, C.-N. Lin, M.-H. Wu, Y.-C. Chen, Y.-L. Chen, and Y.-T. Jin Overexpression of galectin-1 at the tumor invasion front is associated with poor prognosis in early-stage oral squamous cell carcinoma Oral Oncol. 44 2008 325 334
24. X. Sanjuan, P. Fernandez, A. Castells, V. Castronovo, F. Van Den Brule, F. Liu, A. Cardesa, and E. Campo Differential expression of galectin 3 and galectin 1 in colorectal cancer progression Gastroenterology 113 1997 1906 1915
25. X.-C. Xu, A.K. El-Naggar, and R. Lotan Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications Am. J. Pathol. 147 1995 815
26. N.L. Perillo, K.E. Pace, J.J. Seilhamer, and L.G. Baum Apoptosis of T Cells Mediated by Galectin-1 1995
27. K.E. Pace, C. Lee, P.L. Stewart, and L.G. Baum Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1 J. Immunol. 163 1999 3801 3811
28. G. Rabinovich, C. Alonso, C. Sotomayor, S. Durand, J. Bocco, and C. Riera Molecular mechanisms implicated in galectin-1-induced apoptosis: activation of the AP-1 transcription factor and downregulation of Bcl-2 Cell Death Differ. 7 2000 747
29. R. Fajka-Boja, A. Blaskó, F. Kovács-Sólyom, G. Szebeni, G. Tóth, and E. Monostori Co-localization of galectin-1 with GM1 ganglioside in the course of its clathrin-and raft-dependent endocytosis Cell. Mol. Life Sci. 65 2008 2586 2593
30. J. Arii, H. Goto, T. Suenaga, M. Oyama, H. Kozuka-Hata, T. Imai, A. Minowa, H. Akashi, H. Arase, and Y. Kawaoka Non-muscle myosin IIA is a functional entry receptor for herpes simplex virus-1 Nature 467 2010 859 862
31. M. Timmermann, F. Buck, C. Sorg, and P. Högger Interaction of soluble CD163 with activated T lymphocytes involves its association with non-muscle myosin heavy chain type A Immunol. Cell Biol. 82 2004 479 487
32. H. Van Leeuwen, G. Elliott, and P. O'Hare Evidence of a role for nonmuscle myosin II in herpes simplex virus type 1 egress J. Virol. 76 2002 3471 3481
33. C. Hart, L.G. Chase, M. Hajivandi, and B. Agnew Metabolic labeling and click chemistry detection of glycoprotein markers of mesenchymal stem cell differentiation Mesenchymal Stem Cell Assays and Applications 2011 Springer 459 484
34. S. Kawabata, J. Usukura, N. Morone, M. Ito, A. Iwamatsu, K. Kaibuchi, and M. Amano Interaction of Rhokinase with myosin II at stress fibres Genes Cells 9 2004 653 660
35. N.G. Dulyaninova, V.N. Malashkevich, S.C. Almo, and A.R. Bresnick Regulation of myosin-IIA assembly and Mts1 binding by heavy chain phosphorylation Biochemistry 44 2005 6867 6876
36. Z.-H. Li, and A.R. Bresnick The S100A4 metastasis factor regulates cellular motility via a direct interaction with myosin-IIA Cancer Res. 66 2006 5173 5180
37. T. Ilani, G. Vasiliver-Shamis, S. Vardhana, A. Bretscher, and M.L. Dustin T cell antigen receptor signaling and immunological synapse stability require myosin IIA Nat. Immunol. 10 2009 531 539
38. J.F. Hancock Ras proteins: different signals from different locations Nat. Rev. Mol. Cell Biol. 4 2003 373 385
39. A. Paz, R. Haklai, G. Elad-Sfadia, E. Ballan, and Y. Kloog Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation Oncogene 20 2001 7486
40. D.H. Nguyen, A.D. Catling, D.J. Webb, M. Sankovic, L.A. Walker, A.V. Somlyo, M.J. Weber, and S.L. Gonias Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner J. Cell Biol. 146 1999 149 164
41. J.S. Allingham, R. Smith, and I. Rayment The structural basis of blebbistatin inhibition and specificity for myosin II Nat. Struct. Mol. Biol. 12 2005 378 379
42. M. Kovács, J. Tóth, C. Hetényi, A. Málnási-Csizmadia, and J.R. Sellers Mechanism of blebbistatin inhibition of myosin II J. Biol. Chem. 279 2004 35557 35563
43. J. Limouze, A.F. Straight, T. Mitchison, and J.R. Sellers Specificity of blebbistatin, an inhibitor of myosin II J. Muscle Res. Cell Motil. 25 2004 337 341
44. M.S. Duxbury, S.W. Ashley, and E.E. Whang Inhibition of pancreatic adenocarcinoma cellular invasiveness by blebbistatin: a novel myosin II inhibitor Biochem. Biophys. Res. Commun. 313 2004 992 997
45. V. Swaminathan, K. Mythreye, E.T. O'Brien, A. Berchuck, G.C. Blobe, and R. Superfine Mechanical stiffness grades metastatic potential in patient tumor cells and in cancer cell lines Cancer Res. 71 2011 5075 5080
46. V. Sanz-Moreno, C. Gaggioli, M. Yeo, J. Albrengues, F. Wallberg, A. Viros, S. Hooper, R. Mitter, C.C. Féral, and M. Cook ROCK and JAK1 signaling cooperate to control actomyosin contractility in tumor cells and stroma Cancer Cell 20 2011 229 245
47. D.R. Hodge, E.M. Hurt, and W.L. Farrar The role of IL-6 and STAT3 in inflammation and cancer Eur. J. Cancer 41 2005 2502 2512
48. M. Minami, M. Inoue, S. Wei, K. Takeda, M. Matsumoto, T. Kishimoto, and S. Akira STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line Proc. Natl. Acad. Sci. 93 1996 3963 3966
49. M. Kujawski, M. Kortylewski, H. Lee, A. Herrmann, H. Kay, and H. Yu Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice J. Clin. Invest. 118 2008 3367
50. J.A. Fulcher, M.H. Chang, S. Wang, T. Almazan, S.T. Hashimi, A.U. Eriksson, X. Wen, M. Pang, L.G. Baum, and R.R. Singh Galectin-1 co-clusters CD43/CD45 on dendritic cells and induces cell activation and migration through Syk and protein kinase C signaling J. Biol. Chem. 284 2009 26860 26870
51. + regulatory T cells in immunological tolerance to self and non-self Nat. Immunol. 6 2005 345 352